Anders D. Hove, Director at Anacor Pharmaceuticals, Inc. (ANAC), sold 900,000 shares at $111.25 ($100.1M) on 2015-12-15, disclosed to the SEC on 2015-12-17.
Open-market sale of $100.1M ANAC by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ANAC | SELL | 2015-12-15 | $4.7M | — | Filing → |
| ANAC | SELL | 2015-11-12 | $10.4M | — | Filing → |
| EDGE | BUY | 2015-10-08 | $5.0M | — | Filing → |